Wir stellen uns vor
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel, high-quality medicines for people living with rare metabolic diseases.
Lesen Sie mehr